Landmark®

Landmark®
Product Description

Aptar Pharma's Landmark® dose counting device is FDA compliant and compatible with all pMDIs, including nasal actuators. 

Aptar Pharma

  • FR
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Packaging supplier/manufacturer
Primary activities
Contract Research Organisation
Medical Devices
Packaging & drug delivery

Aptar Pharma

  • FR
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Packaging supplier/manufacturer
Primary activities
Contract Research Organisation
Medical Devices
Packaging & drug delivery

More Products from Aptar Pharma (44)

  • UniDose (UDS) System

    Product UniDose (UDS) System

    Aptar Pharma's Unidose systems are nasal drug delivery devices for both liquid and powder forms, enabling precise single-dose delivery without healthcare professional intervention.
  • CPS Technology Platform

    Product CPS Technology Platform

    Aptar Pharma's CPS spray pump offers precise, reliable, and targeted preservative-free nasal drug delivery.
  • Prohaler®

    Product Prohaler®

    Aptar Pharma's Prohaler® is a patient-centric, high-performance DPI that ensures optimal patient compliance in treating asthma, COPD, and other pulmonary conditions.
  • DF 30 Metering Valve

    Product DF 30 Metering Valve

    Aptar Pharma’s DF30 metering valve platform is the industry standard for safe and precise medication delivery to patients with life-threatening pulmonary diseases. It is also the benchmark for hydrofluoralkane (HFA) propellant pMDIs. As the pharmaceutical industry shifts towards environmentally friendl...
  • Activ-Vial™ Portfolio

    Product Activ-Vial™ Portfolio

    Aptar CSP's Activ-Vial™ portfolio offers 3-Phase Activ-Polymer™ flip-top vials and bottles in various sizes, providing superior protection for product stability and extended shelf life.
  • Activ-Film™ Material

    Product Activ-Film™ Material

    Aptar CSP Technologies' Activ-Film™ material optimizes product stability through imperceptible enhancements for consumers and increased efficiency for manufacturers.
  • APF Advanced Preservative Free

    Product APF Advanced Preservative Free

    The Advanced Preservative Free (APF) and APF + pumps are innovative, metal-free dispensing systems for nasal and topical use, providing robust microbiological protection for sensitive formulations. The highly recyclable, all-plastic APF Futurity™ system marks a breakthrough in multidose nasal spray tec...
  • PureHale® Technology Platform

    Product PureHale® Technology Platform

    Aptar Pharma's PureHale® Technology Platform is the first portable, pre-filled nebulizer –like device that, when used with saline or natural ingredient formulations, alleviates upper respiratory symptoms like coughs, colds, allergies, and dry nose and throat.
  • Classic Line and VP6 Technology Platforms

    Product Classic Line and VP6 Technology Platforms

    Aptar Pharma offers versatile and reliable Classic Line and VP6 spray pump technologies for multi-dose dispensing. Our modular solutions cater to diverse global markets, serving a wide range of products, from regulated prescriptions to over-the-counter and consumer health brands.
  • Lyophilization Stoppers

    Product Lyophilization Stoppers

    Aptar Pharma's Lyophilization Stoppers ensure stability and excellent performance during the freeze-drying process.
  • Needle Shields

    Product Needle Shields

    Aptar Pharma leads in elastomeric Rigid Needle Shields (RNS) for PFS and Auto-injector developments. Trusted by top manufacturers, we offer safe, high-quality solutions for injectables.
  • Tip Caps

    Product Tip Caps

    Aptar Pharma is a global leader in elastomeric Tip Caps, offering high-quality Pre-Filled Syringe components with unique rubber formulation for effective drug protection and safety in injectable developments. 

Aptar Pharma resources (3)

  • Video Innovations in Inhalation

    Aptar Pharma's presentation entitled "Innovations in Inhalation" explores the current extensive portfolio of high-quality OINDP (Orally Inhaled and Nasal Drug Products) delivery devices. The presentation also highlights Aptar Pharma's comprehensive services which support respiratory drug development, including device selection, formulation development, analytical methods, and regulatory support. A key focus of the talk is the introduction of Orbital, an innovative high payload DPI system designed to enhance drug delivery efficiency and patient compliance. This discussion aims to showcase Aptar Pharma's latest advancements in inhalation technology, emphasizing their commitment to improving patient care through innovative drug delivery systems.
  • Video The Pharma Challenge With Scope 3 Emissions – Collaborative Ways to Reduce Our CO2 Footprint

    Big Pharma reports that up to over 90% of their CO2 emissions are scope 3. This is not only a huge burden but also the most difficult part to influence for pharmaceutical industry. However, there are ways to manage and collaborate in the industry. Christophe Marie from Aptar Group will highlight how Aptar implemented specific targets with partners and suppliers to tackle the scope 3 challenge, coming from a consumer market perspective, extrapolating into the pharmaceutical business. Also, when talking about products we are increasingly facing requests to minimize our CO2 footprint in Pharma. A great example for collaborative approaches helping to de-risk and accelerate our clients’ low GWP pressurized Metered Dose Inhaler (pMDI) programs will be illustrated by Chris Baron, based on the transition of the current pMDIs to alternative low GWP propellant technologies. Join Christophe Marie and Chris Baron at CPHI to learn how Aptar Pharma supports more sustainable product